Firma Ewopharma, Autor bei Presse-Blog

Ewopharma AG Announces Exclusive Distribution Agreement for Cardiovascular Solutions in Bulgaria

15. April 202511. April 2025 Firma EwopharmaMedizintechnikballoon, coatings, dcb, eluting, ewopharma, healthcare, market, medical, patients, restenosis, solutions, translumina, treatment, vessel, with

Effective June 1, 2024, Ewopharma AG has the exclusive licence to distribute Translumina’s drug-eluting stents (DES) and Blue Medical’s drug-coated balloon (DCB) technologies in Bulgaria. The agreement includes two key categories of interventional cardiovascular solutions: Drug-Eluting Stents – The DES Mehr

AllergyCare AG Becomes Part Of Ewopharma Group

3. Juni 20243. Juni 2024 Firma EwopharmaAllgemeinaida, business, company, customers, ewopharma, health, healthcare, home, market, new, pharmaceutical, privileged, services, treatment, with

Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to announce its acquisition of AllergyCare AG, a Swiss distribution company of pharmaceutical and consumer health products with a focus on the prevention Mehr

Ewopharma and CStone enter into a Strategic Partnership for Sugemalimab in Central Eastern Europe and Switzerland

27. Mai 202427. Mai 2024 Firma EwopharmaAllgemeincancer, cee, cell, clinical, ewopharma, lymphoma, medical, new, nsclc, patients, payment, research, revenues, treatment, with

Ewopharma announces today that it has entered into a strategic commercial collaboration with CStone Pharmaceuticals (“CStone”, HKEX: 2616), an innovationdriven biopharmaceutical company focused on the research and development of anti-cancer therapies. Under the agreement, Ewopharma will gain the commercial rights Mehr

Neomed s.r.o. becomes part of Ewopharma Group

31. Mai 2023 Firma EwopharmaFirmeninterncompany, cosmetic, devices, ewopharma, healthcare, intraocular, lenses, logistics, market, medical, new, patients, pharmaceutical, services, with

Ewopharma AG, a privately held Swiss healthcare group with subsidiaries in Central and Eastern Europe, is pleased to announce its acquisition of Neomed s.r.o., a Czech Distribution company of pharmaceuticals, medical devices, and cosmetics. As part of a succession solution, Mehr

Ewopharma and Vianex announce collaboration to distribute the essential antibiotic Amikacin in Switzerland

29. Juli 201929. Juli 2019 Firma EwopharmaMedizintechnikamikacin, antibiotic, business, drugs, ewopharma, home, market, network, new, pharmaceutical, production, protein, treatment, vianex, with

Ewopharma and Vianex S.A. are pleased to announce their new partnership for distribution of Amikacin in Switzerland. Ewopharma will be the new market authorisation holder for the drug and assuming all responsibilities of the former distributor Bristol Myers Squibb. Amikacin Mehr

Ewopharma and Vianex announce collaboration to distribute the essential antibiotic Amikacin in Switzerland

29. Juli 201929. Juli 2019 Firma EwopharmaMedizintechnikamikacin, antibiotic, business, drugs, ewopharma, home, market, network, new, pharmaceutical, production, protein, treatment, vianex, with

Your one-stop-shop to commercialize your product successfully

12. April 201915. April 2019 Firma EwopharmaFirmenintern??licensing??, Business Development, Central Eastern Europe, Consulting, ewopharma, health, Market Access, marketing, medical, otc, pharma, pharmaceuticals, Switzerland

Getting 60 years in 2019 Ewopharma decided for a new appearance. The adjustments that have been made are a cautious and contemporary development – an evolution not a revolution. The new corporate design coincides with Ewopharma’s expanding role as the trusted Mehr

Autor: Firma Ewopharma